1. Home
  2. Labeler Index
  3. Astrazeneca Ab
  4. 17228-9700
  5. NDC Package Code: 17228-9700-1 Budesonide Micronised Co-suspension Apn

NDC Package 17228-9700-1 Budesonide Micronised Co-suspension Apn

Powder - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
17228-9700-1
Package Description:
6 kg in 1 CAN
Product Code:
17228-9700
Non-Proprietary Name:
Budesonide Micronised Co-suspension Apn
Substance Name:
Budesonide
Usage Information:
Budesonide is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. This medication belongs to a class of drugs known as corticosteroids. It works directly in the lungs to make breathing easier by reducing the irritation and swelling of the airways. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler as prescribed.
11-Digit NDC Billing Format:
17228970001
Product Type:
Bulk Ingredient
Labeler Name:
Astrazeneca Ab
Dosage Form:
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s):
  • BUDESONIDE 6 kg/6kg
    • Sample Package:
    N/A
    Marketing Category:
    BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
    Start Marketing Date:
    03-09-2023
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 17228-9700-1?

    The NDC Packaged Code 17228-9700-1 is assigned to an UNFINISHED drug package of 6 kg in 1 can of Budesonide Micronised Co-suspension Apn, a bulk ingredient labeled by Astrazeneca Ab. The product's dosage form is powder and is administered via form.

    Is NDC 17228-9700 included in the NDC Directory?

    Yes, Budesonide Micronised Co-suspension Apn is an UNFINISHED PRODUCT with code 17228-9700 that is active and included in the NDC Directory. The product was first marketed by Astrazeneca Ab on March 09, 2023 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 17228-9700-1?

    The 11-digit format is 17228970001. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-117228-9700-15-4-217228-9700-01